1. Rayinda, Tuntas, McSweeney, Sheila M, Christou, Evangelos, Simpson, Michael A, Tziotzios, Christos. . Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia. In JAMA dermatology, 160, 732-735. doi:10.1001/jamadermatol.2024.1315. https://pubmed.ncbi.nlm.nih.gov/38809548/
2. Amin, Abdulbasit, Badenes, Marina, Tüshaus, Johanna, Lichtenthaler, Stefan F, Adrain, Colin. 2023. Semaphorin 4B is an ADAM17-cleaved adipokine that inhibits adipocyte differentiation and thermogenesis. In Molecular metabolism, 73, 101731. doi:10.1016/j.molmet.2023.101731. https://pubmed.ncbi.nlm.nih.gov/37121509/
3. Zhang, Zi-Jian, Huang, Yun-Peng, Liu, Zhong-Tao, Wen, Yu, Huang, Sheng-Fu. 2023. Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients. In Frontiers in immunology, 14, 1028404. doi:10.3389/fimmu.2023.1028404. https://pubmed.ncbi.nlm.nih.gov/36817485/
4. Jian, Hong, Liu, Bin, Zhang, Jie. 2014. Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 4949-55. doi:10.1007/s13277-014-1651-4. https://pubmed.ncbi.nlm.nih.gov/24474252/
5. Mindikoglu, Ayse L, Abdulsada, Mustafa M, Jain, Antrix, Opekun, Antone R, Jung, Sung Yun. 2020. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. In Scientific reports, 10, 18341. doi:10.1038/s41598-020-73767-w. https://pubmed.ncbi.nlm.nih.gov/33110154/
6. Nakagawa, Yukinobu, Takamatsu, Hyota, Okuno, Tatsusada, Katayama, Ichiro, Kumanogoh, Atsushi. 2011. Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses. In Journal of immunology (Baltimore, Md. : 1950), 186, 2881-8. doi:10.4049/jimmunol.1003485. https://pubmed.ncbi.nlm.nih.gov/21270411/
7. Peretz, Liat, Besser, Elazar, Hajbi, Renana, Aqeilan, Rami, Behar, Oded. 2018. Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism. In Scientific reports, 8, 93. doi:10.1038/s41598-017-18551-z. https://pubmed.ncbi.nlm.nih.gov/29311693/
智鼠故事 
